392 related articles for article (PubMed ID: 29505935)
21. [Synthesis and anticancer activity of 3-[(3'-methyl-4'-(substituted phenyl)-1',3'-butadienyl] indole derivatives].
Xu L; Liu J; Xu SP
Yao Xue Xue Bao; 2001 Jan; 36(1):29-33. PubMed ID: 12579856
[TBL] [Abstract][Full Text] [Related]
22. Steering the antitumor drug discovery campaign towards structurally diverse indolines.
Thakur A; Singh A; Kaur N; Ojha R; Nepali K
Bioorg Chem; 2020 Jan; 94():103436. PubMed ID: 31761410
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T
Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315
[TBL] [Abstract][Full Text] [Related]
24. 3-Hydrazinoindolin-2-one derivatives: Chemical classification and investigation of their targets as anticancer agents.
Ibrahim HS; Abou-Seri SM; Abdel-Aziz HA
Eur J Med Chem; 2016 Oct; 122():366-381. PubMed ID: 27391135
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and pro-apoptotic antitumour properties of indole-based 3,5-disubstituted oxadiazoles.
Ziedan NI; Stefanelli F; Fogli S; Westwell AD
Eur J Med Chem; 2010 Oct; 45(10):4523-30. PubMed ID: 20705365
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of novel indole based small molecules as anticancer agents through SIRT1 inhibition.
Panathur N; Dalimba U; Koushik PV; Alvala M; Yogeeswari P; Sriram D; Kumar V
Eur J Med Chem; 2013 Nov; 69():125-38. PubMed ID: 24013412
[TBL] [Abstract][Full Text] [Related]
27. 1-Phenyl-1H-indole derivatives as a new class of Bcl-2/Mcl-1 dual inhibitors: Design, synthesis, and preliminary biological evaluation.
Xu G; Liu T; Zhou Y; Yang X; Fang H
Bioorg Med Chem; 2017 Oct; 25(20):5548-5556. PubMed ID: 28866374
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of Some Novel Fused Pyrimido[4″,5″:5',6']-[1,2,4]triazino[3',4':3,4] [1,2,4]triazino[5,6-b]indoles with Expected Anticancer Activity.
Ali RS; Saad HA
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562697
[TBL] [Abstract][Full Text] [Related]
29. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives.
Kumari A; Singh RK
Bioorg Chem; 2019 Aug; 89():103021. PubMed ID: 31176854
[TBL] [Abstract][Full Text] [Related]
30. 2-Indolinone a versatile scaffold for treatment of cancer: a patent review (2008-2014).
Leoni A; Locatelli A; Morigi R; Rambaldi M
Expert Opin Ther Pat; 2016; 26(2):149-73. PubMed ID: 26561198
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
32. An insight into the medicinal perspective of synthetic analogs of indole: A review.
Garg V; Maurya RK; Thanikachalam PV; Bansal G; Monga V
Eur J Med Chem; 2019 Oct; 180():562-612. PubMed ID: 31344615
[TBL] [Abstract][Full Text] [Related]
33. Indole-2-carboxylic acid derived mono and bis 1,4-disubstituted 1,2,3-triazoles: Synthesis, characterization and evaluation of anticancer, antibacterial, and DNA-cleavage activities.
Narsimha S; Satheesh Kumar N; Kumara Swamy B; Vasudeva Reddy N; Althaf Hussain SK; Srinivasa Rao M
Bioorg Med Chem Lett; 2016 Mar; 26(6):1639-1644. PubMed ID: 26873415
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis, and Cytotoxic Activities of Indole and Indazole-Based Stilbenes.
Ma Z; Zhang W; Han X; Chen Y; Li G
Chem Biodivers; 2023 May; 20(5):e202300368. PubMed ID: 36996024
[TBL] [Abstract][Full Text] [Related]
35. "On water" expedient synthesis of 3-indolyl-3-hydroxy oxindole derivatives and their anticancer activity in vitro.
Sai Prathima P; Rajesh P; Venkateswara Rao J; Sai Kailash U; Sridhar B; Mohan Rao M
Eur J Med Chem; 2014 Sep; 84():155-9. PubMed ID: 25016373
[TBL] [Abstract][Full Text] [Related]
36. Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.
Chao WR; Yean D; Amin K; Green C; Jong L
J Med Chem; 2007 Jul; 50(15):3412-5. PubMed ID: 17602463
[TBL] [Abstract][Full Text] [Related]
37. Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach.
Devi N; Kaur K; Biharee A; Jaitak V
Anticancer Agents Med Chem; 2021; 21(14):1802-1824. PubMed ID: 33397272
[TBL] [Abstract][Full Text] [Related]
38. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
39. Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.
Kaur K; Jaitak V
Anticancer Agents Med Chem; 2019; 19(8):962-983. PubMed ID: 30864529
[TBL] [Abstract][Full Text] [Related]
40. 3-Aminomethyl derivatives of 4,11-dihydroxynaphtho[2,3-f]indole-5,10-dione for circumvention of anticancer drug resistance.
Shchekotikhin AE; Shtil AA; Luzikov YN; Bobrysheva TV; Buyanov VN; Preobrazhenskaya MN
Bioorg Med Chem; 2005 Mar; 13(6):2285-91. PubMed ID: 15727877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
